ArriVent BioPharma (AVBP) Shares Outstanding (2023 - 2026)

ArriVent BioPharma (AVBP) Shares Outstanding (2023 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 6,012.74 Bn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 47.82 Bn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.44 Bn
4 NuCana 279.75 Bn 279.75 Bn - 11.23 Bn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 254.10 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 104.00 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - 400.00 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 62.19 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 198.10 Mn
10 ArriVent BioPharma 1.42 Bn 1.42 Bn - 45.07 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 45.07 Mn
Dec 31, 2025 38.46 Mn
Sep 30, 2025 41.91 Mn
Jun 30, 2025 35.01 Mn
Mar 31, 2025 33.90 Mn
Dec 31, 2024 31.47 Mn
Sep 30, 2024 33.58 Mn
Jun 30, 2024 33.50 Mn
Mar 31, 2024 25.05 Mn
Dec 31, 2023 2.14 Mn
Sep 30, 2023 2.61 Mn
Jun 30, 2023 2.00 Mn
Mar 31, 2023 1.29 Mn